At the news
? NEUTRALIMPACT 2/10 144 filed Nov 16, 2026 at 16:08 ET
Director Robert F. Werner filed a Form 144 to sell 1,637 shares of Twist Bioscience common stock, with an estimated aggregate value of approximately $169,738. The sale is to cover a tax obligation from a vested equity award distribution. The filing is a routine insider transaction for tax withholding purposes and does not signal a change in the insider's view of the company.
- Robert F. Werner, an officer of Twist Bioscience, filed Form 144 to sell 1,637 shares of common stock.
- Estimated aggregate market value of the proposed sale is $169,737.91.
- The sale is intended to cover a tax obligation resulting from the settlement of a vested equity award distribution.
- The proposed sale date is November 16, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access